Alzamend Neuro logo

Alzamend NeuroNASDAQ: ALZN

Profile

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

15 June 2021

Next earnings report:

13 December 2024

Last dividends:

N/A

Next dividends:

N/A
$6.11 M
-97%vs. 3y high
14%vs. sector
-vs. 3y high
-vs. sector
-120%vs. 3y high
5%vs. sector
-vs. 3y high
-vs. sector

Price

after hours | 17 min ago
$1.57-$0.07(-4.27%)

Dividend

No data over the past 3 years
No data over the past 3 years

Analysts recommendations

Institutional Ownership

ALZN Latest News

3 Biotech Stocks That Could Turn $1,000 into $10,000 by 2024
InvestorPlace24 May 2023 Sentiment: POSITIVE

Developing groundbreaking drugs and devices entails high costs, uncertain regulatory approval, and lucrative revenues. Those factors and more culminate to create a sector filled with dozens of biotech stocks that have 10X potential, or better.

3 Penny Stocks That Could Turn $1,000 into $10,000 in a Year
InvestorPlace11 May 2023 Sentiment: NEGATIVE

Turning $1,000 into $10,000 in a year in the stock market is undoubtedly a lofty goal. Make no bones about it, it's not particularly likely to happen.

What type of business is Alzamend Neuro?

Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. Its pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002 stage, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. The company has partnership agreement with Massachusetts General Hospital for the Phase II clinical trial of AL001. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia.

What sector is Alzamend Neuro in?

Alzamend Neuro is in the Healthcare sector

What industry is Alzamend Neuro in?

Alzamend Neuro is in the Biotechnology industry

What country is Alzamend Neuro from?

Alzamend Neuro is headquartered in United States

When did Alzamend Neuro go public?

Alzamend Neuro initial public offering (IPO) was on 15 June 2021

What is Alzamend Neuro website?

https://www.alzamend.com

Is Alzamend Neuro in the S&P 500?

No, Alzamend Neuro is not included in the S&P 500 index

Is Alzamend Neuro in the NASDAQ 100?

No, Alzamend Neuro is not included in the NASDAQ 100 index

Is Alzamend Neuro in the Dow Jones?

No, Alzamend Neuro is not included in the Dow Jones index

When was Alzamend Neuro the previous earnings report?

No data

When does Alzamend Neuro earnings report?

The next expected earnings date for Alzamend Neuro is 13 December 2024